Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)
Clinical trial NCT00685776 · COMPLETED
Trial details
- NCT number
- NCT00685776
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-24
- Primary completion
- 2009-07-02
- Enrollment
- 1623
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.